Hims & Hers added Grail’s Galleri multi-cancer blood test to its digital health offerings, expanding consumer access to early cancer screening.
Longevity News
Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings.
Source: FierceBiotech - Medtech • Published: 20 Feb 2026, 04:51
Continue exploring
Related longevity signals
Longevity TechnologyClaremedica’s digital test finds 90% of new dementia cases earlyA report on a primary care group’s adoption of a digital cognitive assessment and what readers will learn about its implementation and uptake.Longevity TechnologyTelehealth longevity platform among XPRIZE Healthspan’s top 10A profile of a telehealth-first longevity provider that earned a Milestone 2 award in the XPRIZE Healthspan competition and plans larger trials.Fight Aging!Bacterial Lipoic Acid Protein Ligase A Improves Mammalian Mitochondrial Function and HealthThis article previews research on using a bacterial enzyme to boost mitochondrial protein modification and overall cellular energy, framed as a potential metabolic-enhancing therapy. It invites readers curious about cross-species gene therapy approaches aimed at improving healthspan and age-related function.Nature - BiotechnologySEQURNA enhances FLASH-seq gene detection while eliminating DTT dependenceSEQURNA-focused methods article presenting a comparative benchmark of a synthetic thermostable RNase inhibitor for improved single-cell, full-length RNA-seq workflows.